Literature DB >> 6691385

Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis.

J Halme, S Becker, R Wing.   

Abstract

Peritoneal fluid was collected from 107 women undergoing laparoscopic sterilization or diagnostic laparoscopy for evaluation of infertility. Cells consisting mainly of macrophages were separated and subjected to sophisticated flow fluorocytometric analysis. In this way more detailed information was obtained about activational characteristics of the pelvic macrophage population during the menstrual cycle. In normal women the macrophages, as compared to peripheral monocytes, showed evidence of elevated baseline activation, and a gradual increase in several markers occurred during the menstrual cycle. Cells increased in size, lost their ability to stain for myeloperoxidase, and increased in activity of both endoenzymes and ectoenzymes. These results suggest that female peritoneal macrophages are continuously responding to stimuli. The macrophage irritation was much more pronounced in women with mild endometriosis. This accentuated cyclic activation may represent an inflammatory response to bleeding from ectopic implants or retrograde menstruation or may be a consequence of some defect in the cell-mediated immune response in endometriosis.

Entities:  

Mesh:

Year:  1984        PMID: 6691385     DOI: 10.1016/s0002-9378(84)80037-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  Human peritoneal macrophages: clinical models of inflammation and potential targets of antiinflammatory drugs.

Authors:  J H Wilson; I L Bonta
Journal:  Agents Actions       Date:  1986-01

2.  Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†.

Authors:  Nikola Sekulovski; Allison E Whorton; Mingxin Shi; James A MacLean; Kanako Hayashi
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

3.  Reciprocal communication between endometrial stromal cells and macrophages.

Authors:  Kathleen M Eyster; Keith A Hansen; Emily Winterton; Olga Klinkova; Donis Drappeau; Connie J Mark-Kappeler
Journal:  Reprod Sci       Date:  2010-07-02       Impact factor: 3.060

4.  Immune interactions in endometriosis.

Authors:  Jennifer L Herington; Kaylon L Bruner-Tran; John A Lucas; Kevin G Osteen
Journal:  Expert Rev Clin Immunol       Date:  2011-09       Impact factor: 4.473

5.  Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes.

Authors:  Kaylon L Bruner-Tran; Alessandra C Carvalho-Macedo; Antoni J Duleba; Marta A Crispens; Kevin G Osteen
Journal:  Fertil Steril       Date:  2009-07-15       Impact factor: 7.329

Review 6.  Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology.

Authors:  K L Bruner-Tran; J L Herington; A J Duleba; H S Taylor; K G Osteen
Journal:  Minerva Ginecol       Date:  2013-04

7.  Endometrial-peritoneal interactions during endometriotic lesion establishment.

Authors:  M Louise Hull; Claudia Rangel Escareno; Jane M Godsland; John R Doig; Claire M Johnson; Stephen C Phillips; Stephen K Smith; Simon Tavaré; Cristin G Print; D Stephen Charnock-Jones
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

8.  Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages.

Authors:  P K Peterson; E Gaziano; H J Suh; M Devalon; L Peterson; W F Keane
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

9.  Immunohistochemical study of HLA-DR antigen in endometrial tissue of patients with endometriosis.

Authors:  Yi Liu; Lilan Luo; Haibo Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

10.  A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium.

Authors:  Erin Greaves; Fiona L Cousins; Alison Murray; Arantza Esnal-Zufiaurre; Amelie Fassbender; Andrew W Horne; Philippa T K Saunders
Journal:  Am J Pathol       Date:  2014-06-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.